Clinical relevance of adding intravascular ultrasound to coronary angiography for the diagnosis of extrinsic left main coronary artery compression by a pulmonary artery aneurysm in pulmonary hypertension.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
10 2021
Historique:
revised: 23 06 2020
received: 16 01 2020
accepted: 19 07 2020
pubmed: 14 8 2020
medline: 21 10 2021
entrez: 14 8 2020
Statut: ppublish

Résumé

We sought to assess the clinical value of adding intravascular ultrasound (IVUS) evaluation to coronary angiography (CA) to guide extrinsic left main coronary artery (LMCA) compression diagnosis and treatment in pulmonary hypertension (PH). LMCA compression due to a pulmonary artery aneurysm (PAA) is a severe complication of PH. Although guidelines encourage the use of IVUS for LMCA disease evaluation, it has hardly been used in this scenario. We analyzed morbimortality of type 1 and 4 PH patients with clinically suspected LMCA compression by a PAA between 2010 and 2018 in a reference unit. LMCA compression was prospectively assessed with CA ± IVUS. Angiographic-LMCA compression was considered conclusive when LMCA stenosis>50% was present in four predetermined projections; inconclusive, when LMCA stenosis>50% was present in <4 projections and negative if no stenosis>50% was present. Patients with conclusive and inconclusive CA underwent IVUS. IVUS-LMCA compression was defined as systolic minimum lumen area < 6 mm LMCA compression was suspected in 23/796 patients (3%). CA was conclusive for compression in 7(30.5%), inconclusive in 9(39%), and negative in 7(30.5%). IVUS confirmed LMCA compression in 6/7(86%) patients with conclusive CA and in 2/9(22%) with inconclusive CA. Patients fulfilling IVUS criteria for LMCA compression underwent stent implantation. At 20 months follow-up a composite end-point of death, stent restenosis/thrombosis, or lung transplant was reported in three patients (13%). CA can misdiagnose LMCA extrinsic compression. IVUS discriminates better whether significant compression by a PAA exists or not, avoiding unnecessary LMCA stenting. Patients treated following this strategy show a low rate of major clinical events at 20 months follow-up.

Sections du résumé

OBJECTIVES
We sought to assess the clinical value of adding intravascular ultrasound (IVUS) evaluation to coronary angiography (CA) to guide extrinsic left main coronary artery (LMCA) compression diagnosis and treatment in pulmonary hypertension (PH).
BACKGROUND
LMCA compression due to a pulmonary artery aneurysm (PAA) is a severe complication of PH. Although guidelines encourage the use of IVUS for LMCA disease evaluation, it has hardly been used in this scenario.
METHODS
We analyzed morbimortality of type 1 and 4 PH patients with clinically suspected LMCA compression by a PAA between 2010 and 2018 in a reference unit. LMCA compression was prospectively assessed with CA ± IVUS. Angiographic-LMCA compression was considered conclusive when LMCA stenosis>50% was present in four predetermined projections; inconclusive, when LMCA stenosis>50% was present in <4 projections and negative if no stenosis>50% was present. Patients with conclusive and inconclusive CA underwent IVUS. IVUS-LMCA compression was defined as systolic minimum lumen area < 6 mm
RESULTS
LMCA compression was suspected in 23/796 patients (3%). CA was conclusive for compression in 7(30.5%), inconclusive in 9(39%), and negative in 7(30.5%). IVUS confirmed LMCA compression in 6/7(86%) patients with conclusive CA and in 2/9(22%) with inconclusive CA. Patients fulfilling IVUS criteria for LMCA compression underwent stent implantation. At 20 months follow-up a composite end-point of death, stent restenosis/thrombosis, or lung transplant was reported in three patients (13%).
CONCLUSIONS
CA can misdiagnose LMCA extrinsic compression. IVUS discriminates better whether significant compression by a PAA exists or not, avoiding unnecessary LMCA stenting. Patients treated following this strategy show a low rate of major clinical events at 20 months follow-up.

Identifiants

pubmed: 32790221
doi: 10.1002/ccd.29194
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-700

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Galie N, Channick RN, Frantz RP, et al. Risk stratification and medical therapy of pulmonary arterial hypertension. Eur Respir J. 2019;53:1801889.
Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015;46(4):903-975.
Mesquita SM, Castro CR, Ikari NM, Oliveira SA, Lopes AA. Likelihood of left main coronary artery compression based on pulmonary trunk diameter in patients with pulmonary hypertension. Am J Med. 2004;116(6):369-374.
Vaseghi M, Lee MS, Currier J, Tobis J, Shapiro S, Aboulhosn J. Percutaneous intervention of left main coronary artery compression by pulmonary artery aneurysm. Catheter Cardiovasc Interv. 2010;76:352-356.
Greyson CR. The right ventricle and pulmonary circulation: basic concepts. Rev Esp Cardiol. 2010;63(1):81-95.
Crystal GJ, Pagel PS. Right ventricular perfusion: physiology and clinical implications. Anesthesiology. 2018;128:202-218.
Galie N, Saia F, Palazzini M, et al. Left main coronary artery compression in patients with pulmonary arterial hypertension and angina. J Am Coll Cardiol. 2017;69(23):2808-2817.
Nuche J, Montero Cabezas JM, Jimenez Lopez-Guarch C, et al. Frequency, predictors, and prognostic impact of pulmonary artery aneurysms in patients with pulmonary arterial hypertension. Am J Cardiol. 2019;123(3):474-481.
Akbal OY, Kaymaz C, Tanboga IH, et al. Extrinsic compression of left main coronary artery by aneurysmal pulmonary artery in severe pulmonary hypertension: its correlates, clinical impact, and management strategies. Eur Heart J Cardiovasc Imaging. 2018;19(11):1302-1308.
Żyłkowska J, Kurzyna M, Florczyk M, et al. Pulmonary artery dilatation correlates with the risk of unexpected death in chronic arterial or thromboembolic pulmonary hypertension. Chest. 2012;142(6):1406-1416.
Hamilos M, Muller O, Cuisset T, et al. Long term clinical outcome after fractional flow reserve guided treatment in patients with angiographically equivocal left main coronary artery stenosis. Circulation. 2009;120(15):1505-1512.
De la Torre Hernandez JM, Hernandez Hernandez F, et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. J Am Coll Cardiol. 2011;58(4):351-358.
Sano K, Mintz GS, Carlier SG, et al. Assessing intermediate left main coronary lesions using intravascular ultrasound. Am Heart J. 2007;154:983-988.
Räber L, Mintz GS, Koskinas KC, et al. ESC Scientific Document Group. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281-3300.
Kreibich M, Siepe M, Kroll J, Hohn R, Grohmann J, Beyersdorf F. Aneurysms of the pulmonary artery. Circulation. 2015;131:310-316.
Belardinelli R, Lacalaprice F, Tiano L, Muçai A, Perna GP. Cardiopulmonary exercise testing is more accurate than ECG-stress testing in diagnosing myochardial ischemia in subjets with chest pain. Int J Cardiol. 2014;174:337-342.
Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2018;53(1):34-78.
Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007;115:2344-2351.
Lee SE, Im JH, Sung JM, et al. Detection of mechanical complications related to the potential risk of sudden cardiac death in patients with pulmonary arterial hypertension by computed tomography. Int J Cardiol. 2017;243:460-465.
Montero Cabezas JM, Nuche Berenguer J, Velázquez Martín MT, Escribano Subías P. Left main extrinsic compression in pulmonary arterial hypertension. J Am Coll Cardiol. 2017;70:2459-2460.
Saia F, Palazzini M, Taglieri MA, Dardi F, Rinaldi A. Left main extrinsic compression in pulmonary arterial hypertension. Reply. J Am Coll Cardiol. 2017;70:2460-2461.
Saia F, Dall'Ara G, Marzocchi A, et al. Left main coronary artery extrinsic compression in patients with pulmonary arterial hypertension. J Am Coll Cardiol Intv. 2019;12:319-321.
Adigopula S, Nsair A. Left main coronary artery stent migration. N Engl J Med. 2015;373:1957.

Auteurs

Maite Velázquez Martín (M)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

José M Montero Cabezas (JM)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Sergio Huertas (S)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Jorge Nuche (J)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Agustín Albarrán (A)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Juan F Delgado (JF)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Sergio Alonso (S)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Fernando Sarnago (F)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Fernando Arribas (F)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Pilar Escribano Subias (P)

Department of Cardiology, University Hospital 12 de Octubre, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH